Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada; Institut national de santé publique du Québec, Montreal, Quebec, Canada.
Division of Cardiology, Department of Medicine, University of Montreal Hospital Centre, Quebec, Canada; University of Montreal Hospital Research Centre, Quebec, Canada.
Am J Med. 2022 Aug;135(8):993-1000.e1. doi: 10.1016/j.amjmed.2022.04.002. Epub 2022 Apr 25.
Cocaine is associated with acute cardiovascular complications, but the long-term cardiovascular risks of cocaine use are poorly understood. We examined the association between cocaine use disorders and long-term cardiovascular morbidity in women.
We analyzed a longitudinal cohort of 1,296,463 women in Quebec, Canada between 1989 and 2020. The exposure included cocaine use disorders prior to or during pregnancy. The outcome was cardiovascular hospitalization up to 31 years later. We used adjusted Cox regression models to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the association of cocaine use disorders with cardiovascular hospitalization.
The cohort included 2954 women with cocaine use disorders. Compared with women without an identified cocaine disorder, women with cocaine use disorders had 1.55 times greater risk of future cardiovascular hospitalization during 3 decades of follow-up (95% CI, 1.37-1.75). Cocaine use disorders were strongly associated with inflammatory heart disease (HR 4.82; 95% CI, 2.97-7.83), cardiac arrest (HR 2.93; 95% CI, 1.46-5.88), valve disease (HR 3.09; 95% CI, 2.11-4.51), and arterial embolism (HR 2.22; 95% CI, 1.19-4.14). The association between cocaine use disorder and cardiovascular hospitalization was most marked after 5 to 10 years of follow-up (HR 2.15; 95% CI, 1.70-2.72).
Women with cocaine use disorders have a high risk of cardiovascular hospitalization up to 3 decades later. Substance use reduction and cardiovascular risk surveillance may help reduce the burden of cardiovascular disease in women with cocaine use disorders.
可卡因与急性心血管并发症有关,但可卡因使用的长期心血管风险尚不清楚。我们研究了可卡因使用障碍与女性长期心血管发病率之间的关系。
我们分析了加拿大魁北克省 1989 年至 2020 年间的 1296463 名女性的纵向队列。暴露因素包括妊娠前或妊娠期间的可卡因使用障碍。结局是 31 年后的心血管住院情况。我们使用调整后的 Cox 回归模型来估计可卡因使用障碍与心血管住院之间的关联的风险比(HR)和 95%置信区间(CI)。
该队列包括 2954 名可卡因使用障碍女性。与未确诊可卡因障碍的女性相比,可卡因使用障碍女性在 30 年的随访期间发生心血管住院的风险增加了 1.55 倍(95%CI,1.37-1.75)。可卡因使用障碍与炎症性心脏病(HR 4.82;95%CI,2.97-7.83)、心脏骤停(HR 2.93;95%CI,1.46-5.88)、瓣膜病(HR 3.09;95%CI,2.11-4.51)和动脉栓塞(HR 2.22;95%CI,1.19-4.14)密切相关。在随访 5 至 10 年后,可卡因使用障碍与心血管住院之间的关联最为显著(HR 2.15;95%CI,1.70-2.72)。
可卡因使用障碍的女性在 30 年后有发生心血管住院的高风险。减少物质使用和心血管风险监测可能有助于降低可卡因使用障碍女性的心血管疾病负担。